Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2577121rdf:typepubmed:Citationlld:pubmed
pubmed-article:2577121lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C1155065lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C1158419lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C1157383lld:lifeskim
pubmed-article:2577121lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2577121pubmed:issue1lld:pubmed
pubmed-article:2577121pubmed:dateCreated1990-10-12lld:pubmed
pubmed-article:2577121pubmed:abstractTextActivation of Jurkat T lymphocytes to produce IL2 is accompanied by a strong inhibition of phosphatidylserine (PS) synthesis. This inhibition was obtained either with the mitogenic lectin PHA, anti-CD3 monoclonal antibodies (mAb), anti-CD2 mAb or anti-Ti mAb. Bypassing membrane receptor signalling, by using a Ca2+ ionophore or a protein phosphatase inhibitor, sodium ortho-vanadate, also results in a marked inhibition of PS synthesis. Activators of phospholipid -Ca2+ dependent protein kinase C (PKC) did not significantly modify PS synthesis, suggesting that the observed changes only involve the transduction of the first activation signal. PS being a necessary cofactor for PKC, our results strongly suggest that the inhibition of PS synthesis induced by receptor triggering exerts a feed back control on PKC therefore leading to a transient activation of the enzyme upon full lymphocyte activation.lld:pubmed
pubmed-article:2577121pubmed:languageenglld:pubmed
pubmed-article:2577121pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:citationSubsetIMlld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2577121pubmed:statusMEDLINElld:pubmed
pubmed-article:2577121pubmed:issn0898-6568lld:pubmed
pubmed-article:2577121pubmed:authorpubmed-author:AusselCClld:pubmed
pubmed-article:2577121pubmed:authorpubmed-author:FehlmannMMlld:pubmed
pubmed-article:2577121pubmed:authorpubmed-author:PelassyCClld:pubmed
pubmed-article:2577121pubmed:issnTypePrintlld:pubmed
pubmed-article:2577121pubmed:volume1lld:pubmed
pubmed-article:2577121pubmed:ownerNLMlld:pubmed
pubmed-article:2577121pubmed:authorsCompleteYlld:pubmed
pubmed-article:2577121pubmed:pagination99-105lld:pubmed
pubmed-article:2577121pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:meshHeadingpubmed-meshheading:2577121-...lld:pubmed
pubmed-article:2577121pubmed:year1989lld:pubmed
pubmed-article:2577121pubmed:articleTitlePhospholipid metabolism and T cell activation: receptor triggering is associated with the inhibition of phosphatidylserine synthesis.lld:pubmed
pubmed-article:2577121pubmed:affiliationINSERM U210, Faculté de Médecine (Pasteur), Nice, France.lld:pubmed
pubmed-article:2577121pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2577121lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2577121lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2577121lld:pubmed